Satellos Bioscience Inc. (MSCL.TO)
CAD 0.89
(-4.3%)
CAD 0.89
(-4.3%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -15.88 Million CAD | -40.34% |
| 2022 | -11.32 Million CAD | 26.98% |
| 2021 | -15.5 Million CAD | -882.28% |
| 2020 | -1.57 Million CAD | 20.62% |
| 2019 | -1.98 Million CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -6.9 Million CAD | -5.72% |
| 2024 Q2 | -6.03 Million CAD | 12.64% |
| 2023 Q3 | -3.57 Million CAD | 13.14% |
| 2023 FY | -15.88 Million CAD | -40.34% |
| 2023 Q2 | -4.11 Million CAD | -146.99% |
| 2023 Q1 | -1.66 Million CAD | 67.15% |
| 2023 Q4 | -6.53 Million CAD | -82.85% |
| 2022 Q4 | -5.07 Million CAD | -167.04% |
| 2022 FY | -11.32 Million CAD | 26.98% |
| 2022 Q3 | -1.89 Million CAD | 0.0% |
| 2021 FY | -15.5 Million CAD | -882.28% |
| 2020 FY | -1.57 Million CAD | 20.62% |
| 2019 FY | -1.98 Million CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Appili Therapeutics Inc. | -3.78 Million CAD | -320.243% |
| Eupraxia Pharmaceuticals Inc. | -37.39 Million CAD | 57.507% |
| Helix BioPharma Corp. | -9.26 Million CAD | -71.513% |
| Microbix Biosystems Inc. | -39.48 Thousand CAD | -40142.636% |
| Medicenna Therapeutics Corp. | -25.46 Million CAD | 37.607% |
| Oncolytics Biotech Inc. | -27.75 Million CAD | 42.746% |
| Sernova Corp. | -38.99 Million CAD | 59.256% |